At a glance
- Originator Nonindustrial source
- Class Antihypertensives; Quinazolines
- Mechanism of Action Alpha 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 31 Jan 2001 No-Development-Reported for Hypertension in Taiwan (Unknown route)
- 03 Mar 1998 Phase-I clinical trials for Hypertension in Taiwan (Unknown route)
- 12 Nov 1997 New profile